Clinical Trial

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

Study acronym: CLIQQC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2026 (before its estimated July 21, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with prostate cancer. It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-16.
Trial Details
NCT Number NCT07484971
Lead Sponsor Société Algérienne de Formation et Recherche en Oncologie
Collaborators: ES Clinical Research, Ipsen, Astellas Pharma Inc
Conditions Prostate Cancer, Prostate Cancer (Diagnosis), Prostate Cancer (Post Prostatectomy), Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer Metastatic, Prostate Cancer (Adenocarcinoma)
Enrollment 2,000 participants
Start Date 2025-07-21
Primary Completion 2026-07-21 (estimated)
Study Completion 2026-07-21 (estimated)
Updated on ClinicalTrials.gov 2026-04-17